Article
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of…
medRxiv · 2022 · Jacob, J.; Francisco, L. E.; Chatterjee, T.; Liang, Z.; Subramanian, S.; Liu, Q. J.; Rowe, J. H.; Carmon, K. S.
Key facts
| Title | An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer |
|---|---|
| First author | Jacob, J.; Francisco, L. E.; Chatterjee, T.; Liang, Z.; Subramanian, S.; Liu, Q. J.; Rowe, J. H.; Carmon, K. S. |
| Journal | medRxiv |
| Published | Aug 14, 2022 |
| DOI | 10.1101/2022.08.11.503187 |
| Devices mentioned | BK110039, K103302 |
| Product codes mentioned | KIT, MVU, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1